West Virginia University Logo


Showing items through of articles.
  • WVU in the News - Study aims to increase effectiveness of opioid addiction treatment

    Tuesday, August 15, 2017

    A new study being conducted at WVU is aimed at increasing the effectiveness of addiction treatment. As many as 20 percent of people addicted to opioids will not respond to the standard treatment of suboxone. Genetic background is one of several factors WVU and the West Virginia Clinical and Translation Science Institute will study to provide better more patient-specific addiction treatment. Get the full story on WV Always.

  • Festival of Ideas presents ‘Opioid Crisis in America’ with Dr. Petros Levounis

    Thursday, August 10, 2017

    Join Dr. Petros Levounis as he discusses the opioid crisis of the 21st century. The opioid crisis can be traced back to the 1980s when a catastrophic medical mistake opened the door to liberal prescribing of narcotics. The perfect storm of powerful molecules, complex brain physiology, and an over-aggressive pharmaceutical industry, which capitalized on that original error, lead to the current epidemic.

  • WVU offers one of only six programs in the nation for Predoctoral Training at the Interface of the Behavioral and Biomedical Sciences.

    Friday, August 4, 2017

    West Virginia University is committed to training the next generation of health researchers who work at the interface of behavioral and biomedical sciences. Through its Research Training Program in Behavioral and Biomedical Sciences (BBS), supported by the National Institute of General Medical Sciences, WVU sponsors six student traineeships each year. The program is supported by one of only six training awards throughout the nation. One of the main challenges of this training program is to bridge scientific and cultural differences between disciplines.

  • Summer research fellows and Shepherd Univ. intern present their cancer research

    Friday, August 4, 2017

    Six undergraduate students recently presented their cancer research to their peers and mentors during a symposium at the WVU Cancer Institute’s Mary Babb Randolph Cancer Center. Five of the undergraduates – Daniel Berrebi, River Hames, Emmanuel Chan, Stephen Chen and Joseph McGuire – completed research fellowships at the WVU Cancer Institute this summer. Adam Hull, an intern from Shepherd University, completed his cancer research project in Shepherd University President Mary Hendrix’s lab at WVU.

  • WVCTSI and WVU research aims to increase addiction treatment effectiveness

    Thursday, July 13, 2017

    MORGANTOWN, W.Va. – Up to 20 percent of people with opioid use disorder may not respond to standard treatment. A new study at West Virginia University seeks to understand why.

  • Town hall to focus on critical care and trauma

    Monday, July 10, 2017

    Critical care and trauma specialist Alison Wilson, MD, will be the special guest at an open forum for Health Sciences and WVU Medicine faculty, staff, and students at noon on Tuesday in the Okey Patteson Auditorium of the WVU Health Sciences Center.

  • WVU School of Public Health welcomes new faculty and department chair

    Wednesday, July 5, 2017

    The West Virginia University School of Public Health welcomes three new faculty members this month, including a new department chair. School of Public Health Dean Jeffrey Coben says the new faculty members will open doors to new collaborations for both faculty and students. “By bringing on high-caliber faculty members like Drs. Huzurbazar, Bhandari and Allen, we will continue to provide our students access to seasoned practitioners, researchers and experts for a balanced public health education and to build on the important work we are doing for the state’s citizens.”

  • Leukemia Research Foundation supports cancer research at WVU

    Wednesday, July 5, 2017

    The Leukemia Research Foundation has awarded $100,000 to Wei Du, M.D., Ph.D., of the West Virginia University Cancer Institute to investigate a method for increasing the effectiveness of stem cell transplantation.

  • PP&N PhD candidate Abukabda publishes on cardiovascular effects of TiO2 nanoparticles

    Sunday, July 2, 2017

    Nano-sized particles of titanium dioxide (TiO2) are considered as valuable ultrafine whitening powders and are used in applications such as cosmetics, sunscreens, pharmaceuticals, and high-grade plastics. Alaeddin Abukabda and his research mentor, Dr. Tim Nurkiewicz of the WVU Department of Physiology, Pharmacology & Neuroscience, have recently published a paper in the journal Frontiers in Cardiovascular Medicine. Alaeddin studied rats exposed to nano-TiO2 particles and observed that extrapulmonary toxicity is most robust in the arterioles. He determined this using wire myography with larger arteries and pressure myography with arterioles. The mechanism is thought to be endothelium-dependent as the toxicity gradient was observed only in response to acetylcholine (and not sodium nitroprusside nor phenylephrine).